CYB5R2 was shown to upregulate genes that negatively impact angiogenesis in nasopharyngeal cancer cells and downregulate expression of vascular endothelial growth factor, thereby suppressing angiogenesis and tumor migration (33). This evidence concerns the gene CYB5R2 and neoplasm.